Analysis Life Sciences Thank You What We Expect the FDA to do in October 2023
Agency IQ
SEPTEMBER 29, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94 to include devices.
40 
Let's personalize your content